Molecular Solutions
Fast, accurate, and reliable molecular diagnostic kits represent a cornerstone in the modern healthcare landscape, offering a pivotal tool for the timely detection and management of various diseases. These kits, which leverage advanced molecular techniques such as polymerase chain reaction (PCR) , enable healthcare professionals to identify pathogens and genetic mutations with unprecedented speed and precision.
This kit is designed for the qualitative detection and genotyping of human papillomavirus (HPV) DNA in cervical or vaginal specimens.
The Stark MTB Molecular Diagnostic Kit is an in vitro nucleic acid amplification test designed for the detection of all members of the M. tuberculosis complex (M. tuberculosis, M. africanum, M. bovis, M. bovis BCG, M. microti, M. pinnipedii) in human sputum, bronchoalveolar lavage (BAL), bronchial secretion, cerebrospinal fluid (CSF), stomach fluid, or peritoneal puncture samples.
This kit is designed for the qualitative detection and quantitative determination of Hepatitis B Virus (HBV) DNA in blood samples, the results derived from this test are intended for clinical interpretation.
The Stark SARS-CoV-2 and Influenza A/B Molecular Diagnostic Kit is designed for accurate detection of the N gene of SARS-CoV-2, the Matrix Protein gene of Influenza A, and the NS1 gene of Influenza B in individuals suspected of infection.
The Stark Sars-CoV-2 Molecular Diagnostic kit is a Real-Time reverse transcription-polymerase chain reaction (rRT-PCR) test specifically designed for the detection of RNA from SARS-CoV-2 in respiratory specimens obtained from patients suspected of COVID-19 by their healthcare provider.
